Observational study finds dosing based on postmenstrual age achieves therapeutic levels in infants, indicating better management strategies.
Subjects with lower postmenstrual ages required significantly higher enoxaparin doses to achieve therapeutic anti-factor Xa concentrations. Postmenstrual age may provide a more appropriate basis for dosing enoxaparin compared with gestational age and postnatal age.
No takes yet. Share an insight, caveat, or question.
Perez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: